BOULDER, Colo. (AP) — Brickell Biotech, Inc. (BBI) on Thursday reported a loss of $4.3 million in its third quarter.
On a per-share basis, the Boulder, Colorado-based company said it had a loss of 15 cents.
The drug developer posted revenue of $142,000 in the period.
In the final minutes of trading on Thursday, the company's shares hit 54 cents. A year ago, they were trading at $2.15.